A Study to Evaluate the Pharmacokinetics of Tadalafil Administered Once Daily in Japanese and Non-Japanese Subjects With Benign Prostatic Hyperplasia.

Trial Profile

A Study to Evaluate the Pharmacokinetics of Tadalafil Administered Once Daily in Japanese and Non-Japanese Subjects With Benign Prostatic Hyperplasia.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Sep 2013

At a glance

  • Drugs Tadalafil (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Pharmacokinetics
  • Sponsors Eli Lilly
  • Most Recent Events

    • 21 Nov 2012 New source identified and integrated (German Clinical Trials Register: DRKS00004062).
    • 15 May 2012 Actual number of patients changed from 12 to 24 as reported by ClinicalTrials.gov.
    • 11 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top